Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT)
ARCT Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-31.50%
Analyst Rating:
BUY
Analyst Forecast (1yr):
229.70%
ARCT Stock Analysis
ARCT
PE Ratio:
ARCT
PEG Ratio:
Not Available
ARCT
Forward EPS Growth (12 month):
0.00%
ARCT
PS Ratio:
3.9
ARCT
PSG Ratio:
-0.1
ARCT
Forward Revenue Growth (12 month):
-28.30%
ARCT Articles
No data was found